scholarly journals Management of retroperitoneal sarcoma involving the iliac artery: Single-center surgical experience

2022 ◽  
Vol 10 (3) ◽  
pp. 811-819
Author(s):  
Wen-Xiang Li ◽  
Han-Xing Tong ◽  
Chen-Tao Lv ◽  
Hua Yang ◽  
Gang Zhao ◽  
...  
2014 ◽  
Vol 25 (3) ◽  
pp. S12
Author(s):  
N.E. Tabori ◽  
A.M. Fischman ◽  
R.S. Patel ◽  
E. Kim ◽  
S.F. Nowakowski ◽  
...  

2019 ◽  
Vol 65 (2-3) ◽  
pp. 69-74 ◽  
Author(s):  
S.Y. Elhadji Cheikh Ndiaye ◽  
L. Troude ◽  
M. Al-Falasi ◽  
M. Faye ◽  
A. Melot ◽  
...  

Vascular ◽  
2020 ◽  
pp. 170853812094542
Author(s):  
Giovanni F Torsello ◽  
Beatrix Doerr ◽  
Konstantinos Donas ◽  
Bärbel Berekoven ◽  
Giovanni B Torsello ◽  
...  

Objectives Endovascular therapy using balloon expandable stents has become the treatment standard for most iliac atherosclerotic lesions. We aimed to assess the safety and performance of the Dynamic stainless-steel balloon-expanding stent system in this location. Methods BIODYNAMIC is a retrospective single center study including consecutive patients with iliac lesions treated with the Dynamic stent system. Not included were implantations inside an endograft. The primary endpoint was freedom from major adverse limb events (MALE) at 12 months, defined as index limb amputation or target lesion revascularization (TLR). Secondary endpoints were procedure success, ankle brachial index (ABI) and Rutherford class change, mortality and freedom from TLR after 12 months. Results Within two years, 182 patients with 234 lesions in the common iliac artery were enrolled. Rutherford class 5 and 6 were present in 11.5% of patients, average stent diameter was 8.0 ± 0.5 mm and stented length 40.0 ± 15.3 mm. The primary endpoint was reached in 96.2% (225/234) of the cases, with six TLR (2.6%) and three target limb amputations (1.3%). Procedure success was obtained in all but three patients (98.4%). In paired analysis, ABI improved by 0.25 ± 0.21 from baseline to 0.90 ± 0.16 post-procedure and Rutherford class improved by −1.75 ± 1.53. There were four non-device–related deaths (2.2%). Freedom from TLR was 97%, 95.3%, 94% and 92.7% at 24, 36, 48 and 60 months, respectively. Conclusion The Dynamic balloon-expandable stent system proved to be safe and effective in a population with common iliac artery lesions.


2016 ◽  
Vol 30 ◽  
pp. 166-174 ◽  
Author(s):  
Bianca Pane ◽  
Giovanni Spinella ◽  
Cecilia Perfumo ◽  
Domenico Palombo

Vascular ◽  
2016 ◽  
Vol 25 (2) ◽  
pp. 190-195 ◽  
Author(s):  
Steven MM van Sterkenburg ◽  
Leo H van den Ham ◽  
Luuk Smeets ◽  
Jan-Willem Lardenoije ◽  
Michel MPJ Reijnen

Introduction Concomitant abdominal aortic aneurysm formation and aortoiliac occlusive disease is a challenging combination, often requiring open reconstructive surgery. In this study, we have assessed a single center experience of the Nellix EndoVascular Aneurysm Sealing System in the treatment of an abdominal aortic aneurysm in conjunction with iliac artery occlusive disease. Methods Retrospectively case files of patients treated with Nellix EndoVascular Aneurysm Sealing System in a single center were reviewed. The primary endpoints of the study were the technical success of Nellix EndoVascular Aneurysm Sealing System in patients with coincidental iliac artery occlusive disease and the successful exclusion of the aneurysm during follow-up. Results Of the 96 patients that were treated with Nellix EndoVascular Aneurysm Sealing System, five were identified that had an abdominal aortic aneurysm in conjunction with iliac artery occlusive disease. Treated patients had either unilateral (n = 4) or bilateral (n = 1) common iliac artery occlusive disease varying from 70% stenosis to complete occlusions. The lesion length varied from 5 to 50 mm and in two cases it involved an occluded bare metal stent. The indication for surgery was the abdominal aortic aneurysm in all patients, including three also suffering from claudication. In all patients the iliac artery occlusive disease was pretreated with balloon-expandable covered stents. Technical success was achieved in all five patients. After a median follow-up of nine months all stents were patent with no signs of endoleak and stable aneurysm diameters. All patients were free of intermittent claudication or ischemic wounds. Conclusion Nellix EndoVascular Aneurysm Sealing System seems feasible and safe in patients with a combination of abdominal aortic aneurysm and iliac artery occlusive disease.


Sign in / Sign up

Export Citation Format

Share Document